Navigation Links
Fenwal Named Exclusive Provider of AccuVein's Award-Winning Vein Illumination Device for Blood and Plasma Centers
Date:10/18/2010

LAKE ZURICH, Ill., Oct. 18 /PRNewswire/ -- Fenwal, Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today it has signed a three-year, exclusive agreement with AccuVein LLC to sell, market and distribute the AccuVein AV300 vein illumination device to blood and plasma centers in North America.

(Photo:  http://photos.prnewswire.com/prnh/20101018/CG83159)

(Photo:  http://www.newscom.com/cgi-bin/prnh/20101018/CG83159)

The AccuVein AV300 is the first hand-held, non-contact, vein illumination device designed to assist medical professionals in locating veins for blood donation, injection and for starting patients on intravenous fluids.  

Held about seven inches above the skin, the device detects hemoglobin in veins and projects a map of the veins on the skin's surface.  For medical professionals, donors and patients, this can make locating needle placement a much easier and more comfortable experience.

The AccuVein AV300 received the 2010 Medical Design Excellence Award, the premier awards program for the medical technology community, and was named a 2009 Best New Product for Pediatricians by Contemporary Pediatrics magazine.  

"The response to the AccuVein AV300 in tests with U.S. blood centers was overwhelmingly positive," said Dean Gregory, Fenwal senior vice president of Commercial Operations.  "Staff and donors see this as an innovation that makes an immediate difference in donor comfort, while improving center productivity and increasing collections."

In evaluations during two community blood drives, the device helped increase collections by reducing by 75 percent deferrals due to difficulty with vein location.  In a recent AccuVein survey, eight out of 10 blood donors reported they would be more likely to donate if vein illumination was used.

"Fenwal is a trusted leader in transfusion medicine," said Vinny Luciano, AccuVein vice president.  "Fenwal's broad knowledge and extensive reach across blood and plasma centers will help us assure all health care practitioners have access to the AccuVein illumination device and the benefits it provides to practitioners, patients and donors."

About Fenwal

Fenwal, Inc. is a global medical technology company focused on improving blood collection, filtration, separation, storage and transfusion to ensure the availability, safety and effectiveness of blood components.  Fenwal is unique in the depth of its experience and commitment to transfusion medicine.  The company offers the broadest range of products for the automated and manual collection of blood and blood components.  Fenwal became an independent company in 2007, but its roots go back to 1949 with the founding of Fenwal Laboratories.  Fenwal developed the first flexible, single-use container for blood collection, eliminating complications associated with glass containers and allowing blood to be separated into therapeutic components.  Today, the company's products and advanced collection and separation technologies are used to help treat patients on six continents.  Fenwal, Inc. is based in Lake Zurich, Illinois.  For more information, please visit www.fenwalinc.com.

About AccuVein

AccuVein LLC is a supplier of innovative, cutting-edge medical devices. The AV300 is a breakthrough product, allowing health care providers to see a map of the position of peripheral veins on the skin's surface with the goal of helping to improve venipuncture procedures. Built using AccuVein's expertise in medical device miniaturization and user-intuitive design, the AV300 is the world's first portable, non-contact vein illumination solution. AccuVein has filed applications for more than a dozen patents on the AV300's technology.  It is in use at more than 300 U.S. hospitals and available for sale in 50 countries.  For more information on AccuVein's AV300, please visit www.accuvein.com


'/>"/>
SOURCE Fenwal, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. FDA Clears Software Upgrade for Fenwal Plasma-Collection System
2. Appellate Court Decides in Favor of Fenwal
3. Fenwal Receives FDA Clearance for Amicus(R) Separator With Wireless Connectivity
4. FDA Clears the Fenwal Amicus(R) Separator System for Collecting Platelets in New Additive Solution
5. Fenwal Responds to New Lawsuit From Haemonetics; Reiterates Commitment to Blood Centers
6. Fenwal Receives FDA Approval for New Solution Used to Store Donated Blood Platelets
7. William Cork Joins Fenwal as Chief Technology Officer
8. Stop Aging Now Named to Prestigious Inc. 5000 List
9. Abbott Named One of the Top Employers in the Biotech and Pharmaceutical Industry by Science Magazine
10. Open Door Family Medical Centers Named Top Community Health Center in Nation for Use of Information Technology
11. AlloSource Named Colorados Top Healthcare Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... FRANKLIN, Tenn. , June 23, 2016 ... for automating, integrating and transforming the patient ... launch of several innovative new products and ... depth of its revenue cycle offerings. These ... establish more efficient workflows, remain compliant in ...
(Date:6/23/2016)... , June 23, 2016 Leading ... that address medical conditions resulting from a breakdown ... has appointed Greg Doyle as chief ... Leading BioSciences, executive management team and board of ... chief financial officer. He will provide continued leadership ...
(Date:6/23/2016)... -- On Wednesday, June 22, 2016, the NASDAQ ... Dow Jones Industrial Average edged 0.27% lower to finish at ... Stock-Callers.com has initiated coverage on the following equities: Alkermes PLC ... AMAG ), IDEXX Laboratories Inc. (NASDAQ: IDXX ... Learn more about these stocks by accessing their free trade ...
Breaking Medicine Technology:
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... for human induced pluripotent stem (iPS) cells and other difficult to transfect cells, ... Cloning Medium. The PluriQ™ G9™ Gene Editing System is a complete ...
(Date:6/24/2016)... ... June 24, 2016 , ... To ... infrastructure. Most providers, however, are unsure how to move forward, given the need ... define a path forward tailored to an organization’s specific needs. , PYA Principal ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... SpiritQuest Sedona ... heart of West Sedona, surrounded by famous vortex sites: Cathedral Rock, Airport Mesa, and ... partner properties – the Lodge at Sedona as well as the Sedona Rouge, both ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... An ... may expose a possible link between head and neck cancer in individuals with unhealthy ... the study were evaluated based on whether they had gum disease, brushed their teeth ...
(Date:6/23/2016)... ... 23, 2016 , ... SyncDog, Inc. , the leading ... is featured in the current issue of Silicon Review magazine. Silicon ... technology solutions and features them in their magazine. The magazine allows top-level executives ...
Breaking Medicine News(10 mins):